tiprankstipranks
Essex Bio-Technology Limited (HK:1061)
:1061
Hong Kong Market
1061
Essex Bio-Technology
RESEARCH TOOLSreports

Essex Bio-Technology (1061) Ratios

0 Followers

Essex Bio-Technology Ratios

HK:1061's free cash flow for Q4 2025 was HK$0.90. For the 2025 fiscal year, HK:1061's free cash flow was decreased by HK$ and operating cash flow was HK$0.22. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.11 2.11 1.81 1.54 2.16
Quick Ratio
 2.01 2.01 1.73 1.46 2.02
Cash Ratio
 1.02 1.02 0.79 0.63 0.97
Solvency Ratio
 0.32 0.30 0.41 0.37 0.27
Operating Cash Flow Ratio
 0.40 0.40 0.52 0.42 0.68
Short-Term Operating Cash Flow Coverage
 4.43 4.43 5.28 1.44 3.64
Net Current Asset Value
HK$ 542.45MHK$ 542.45MHK$ 423.98MHK$ 341.50MHK$ 232.95M
Leverage Ratios
Debt-to-Assets Ratio
 0.10 0.10 0.06 0.10 0.18
Debt-to-Equity Ratio
 0.14 0.14 0.09 0.15 0.28
Debt-to-Capital Ratio
 0.13 0.13 0.08 0.13 0.22
Long-Term Debt-to-Capital Ratio
 0.10 0.10 0.04 0.02 0.18
Financial Leverage Ratio
 1.45 1.45 1.40 1.47 1.57
Debt Service Coverage Ratio
 4.45 4.08 4.38 1.41 2.39
Interest Coverage Ratio
 49.45 52.52 52.69 27.68 23.79
Debt to Market Cap
 0.17 0.15 0.10 0.19 0.20
Interest Debt Per Share
 0.63 0.63 0.34 0.54 0.87
Net Debt to EBITDA
 -0.99 -1.06 -0.92 -0.52 -0.17
Profitability Margins
Gross Profit Margin
89.20%89.20%89.75%90.20%90.26%
EBIT Margin
22.85%22.63%21.25%21.03%20.64%
EBITDA Margin
24.18%22.63%24.00%24.52%23.79%
Operating Profit Margin
21.31%22.63%19.21%18.18%20.72%
Pretax Profit Margin
22.86%22.86%22.49%20.28%19.76%
Net Profit Margin
17.54%17.54%18.40%16.13%17.11%
Continuous Operations Profit Margin
17.54%17.54%18.40%16.13%17.12%
Net Income Per EBT
76.71%76.71%81.82%79.55%86.58%
EBT Per EBIT
107.31%101.02%117.08%111.50%95.37%
Return on Assets (ROA)
9.11%9.11%10.30%9.73%8.31%
Return on Equity (ROE)
13.57%13.18%14.47%14.31%13.02%
Return on Capital Employed (ROCE)
14.19%15.07%14.10%15.39%12.69%
Return on Invested Capital (ROIC)
10.61%11.27%11.18%10.95%10.46%
Return on Tangible Assets
14.67%14.67%15.03%16.17%13.57%
Earnings Yield
16.45%14.88%18.41%19.70%9.35%
Efficiency Ratios
Receivables Turnover
 2.56 2.56 2.71 2.68 2.64
Payables Turnover
 16.94 16.94 23.26 15.81 12.05
Inventory Turnover
 2.47 2.47 2.90 2.66 1.53
Fixed Asset Turnover
 3.51 3.51 4.03 4.10 3.29
Asset Turnover
 0.52 0.52 0.56 0.60 0.49
Working Capital Turnover Ratio
 2.36 2.54 3.31 3.14 1.74
Cash Conversion Cycle
 268.77 268.77 244.87 250.29 346.06
Days of Sales Outstanding
 142.40 142.40 134.87 136.29 138.51
Days of Inventory Outstanding
 147.92 147.92 125.69 137.09 237.85
Days of Payables Outstanding
 21.54 21.54 15.69 23.09 30.30
Operating Cycle
 290.32 290.32 260.56 273.38 376.36
Cash Flow Ratios
Operating Cash Flow Per Share
 0.54 0.54 0.65 0.59 0.67
Free Cash Flow Per Share
 0.23 0.23 0.57 0.37 0.17
CapEx Per Share
 0.31 0.31 0.08 0.22 0.49
Free Cash Flow to Operating Cash Flow
 0.43 0.43 0.88 0.62 0.26
Dividend Paid and CapEx Coverage Ratio
 1.23 1.23 3.54 2.02 1.13
Capital Expenditure Coverage Ratio
 1.75 1.75 8.30 2.65 1.35
Operating Cash Flow Coverage Ratio
 0.88 0.88 1.97 1.15 0.78
Operating Cash Flow to Sales Ratio
 0.17 0.17 0.22 0.20 0.29
Free Cash Flow Yield
6.81%6.16%19.42%15.12%4.14%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.08 6.72 5.43 5.08 10.69
Price-to-Sales (P/S) Ratio
 1.07 1.18 1.00 0.82 1.83
Price-to-Book (P/B) Ratio
 0.80 0.89 0.79 0.73 1.39
Price-to-Free Cash Flow (P/FCF) Ratio
 14.68 16.23 5.15 6.62 24.14
Price-to-Operating Cash Flow Ratio
 6.31 6.98 4.53 4.12 6.30
Price-to-Earnings Growth (PEG) Ratio
 3.34 1.81 0.53 0.20 -0.31
Price-to-Fair Value
 0.80 0.89 0.79 0.73 1.39
Enterprise Value Multiple
 3.42 4.15 3.24 2.82 7.52
Enterprise Value
 1.50B 1.70B 1.30B 1.18B 2.36B
EV to EBITDA
 3.42 4.15 3.24 2.82 7.52
EV to Sales
 0.83 0.94 0.78 0.69 1.79
EV to Free Cash Flow
 11.37 12.92 4.01 5.59 23.60
EV to Operating Cash Flow
 4.89 5.56 3.52 3.48 6.16
Tangible Book Value Per Share
 1.92 1.92 2.09 1.82 1.19
Shareholders’ Equity Per Share
 4.26 4.26 3.74 3.37 3.02
Tax and Other Ratios
Effective Tax Rate
 0.23 0.23 0.18 0.20 0.13
Revenue Per Share
 3.20 3.20 2.94 2.99 2.30
Net Income Per Share
 0.56 0.56 0.54 0.48 0.39
Tax Burden
 0.77 0.77 0.82 0.80 0.87
Interest Burden
 1.00 1.01 1.06 0.96 0.96
Research & Development to Revenue
 0.01 0.00 0.02 0.02 0.03
SG&A to Revenue
 0.66 0.64 0.69 0.13 0.12
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 0.74 0.74 1.20 1.23 1.47
Currency in HKD